Safety and Efficacy of Rituximab in Childhood-onset Systemic Lupus Erythematosus and Other Rheumatic Diseases.

CONCLUSION: RTX can be safely administered to children and appears to contribute to decreased disease activity and steroid burden. PMID: 25593242 [PubMed - as supplied by publisher]
Source: J Rheumatol - Category: Rheumatology Authors: Tags: J Rheumatol Source Type: research